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Abstract
All basal ganglia subnuclei have recently been identified in lampreys, the phylogenetically oldest group of vertebrates.
Furthermore, the interconnectivity of these nuclei is similar to mammals and tyrosine hydroxylase-positive (dopaminergic)
fibers have been detected within the input layer, the striatum. Striatal processing is critically dependent on the interplay
with the dopamine system, and we explore here whether D2 receptors are expressed in the lamprey striatum and their
potential role. We have identified a cDNA encoding the dopamine D2 receptor from the lamprey brain and the deduced
protein sequence showed close phylogenetic relationship with other vertebrate D2 receptors, and an almost 100% identity
within the transmembrane domains containing the amino acids essential for dopamine binding. There was a strong and
distinct expression of D2 receptor mRNA in a subpopulation of striatal neurons, and in the same region tyrosine
hydroxylase-immunoreactive synaptic terminals were identified at the ultrastructural level. The synaptic incidence of
tyrosine hydroxylase-immunoreactive boutons was highest in a region ventrolateral to the compact layer of striatal neurons,
a region where most striatal dendrites arborise. Application of a D2 receptor agonist modulates striatal neurons by causing
a reduced spike discharge and a diminished post-inhibitory rebound. We conclude that the D2 receptor gene had already
evolved in the earliest group of vertebrates, cyclostomes, when they diverged from the main vertebrate line of evolution
(560 mya), and that it is expressed in striatum where it exerts similar cellular effects to that in other vertebrates. These
results together with our previous published data (Stephenson-Jones et al. 2011, 2012) further emphasize the high degree
of conservation of the basal ganglia, also with regard to the indirect loop, and its role as a basic mechanism for action
selection in all vertebrates.
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Introduction
For an animal to achieve its goal it has to select between
competing actions. A group of subcortical nuclei, the basal ganglia,
play a key role in this process in vertebrates [1–5]. The neuronal
architecture underlying selection is evolutionarily highly con-
served, as all components of the basal ganglia, including the
striatum and homologues of the globus pallidus, substantia nigra
(pars compacta and reticulata (SNr)) and the subthalamic nucleus
(STN), have been identified in the lampreys [6][7], the
phylogenetically oldest vertebrates that diverged from the main
vertebrate line 560 million years ago [8]. Furthermore, the
lamprey striatum receives input from the cortex/pallium and
thalamus [9] and GABAergic striatal neurons in both lampreys
[10] and mammals [11] display inward rectification, a key feature
critical in the expression of basal ganglia function.
Information in the striatum is transmitted monosynaptically by
GABAergic substance P-expressing projection neurons to the
output nuclei of the basal ganglia, the globus pallidus interna (GPi)
and the SNr (direct pathway) or polysynaptically, by enkephalin-
expressing neurons projecting to the GP externa (GPe) and the STN
and thence to the output nuclei (indirect pathway; see [7,12]). A
difference between mammals on one side and lampreys and birds
on the other, however, is that GPi and GPe are intermingled in the
latter group but clearly distinct in mammals [7,13].
The main modulatory input to the striatum is dopaminergic in
both lamprey [9] and mammals (see [14]). The functional role of
dopamine in lampreys was recently studied through dopamine
depletion with methyl-phenyl tetrahydropyridine (MPTP). This
caused a marked hypokinesia, as in Parkinson’s disease, an effect
that was counteracted by treatment with dopamine agonists [15].
Dopamine receptors constitute two structurally and functionally
different classes of dopamine receptors; the D1 receptor class
(D1A/D1 and D1B/D5) and the D2 class (D2, D3 and D4) (see
[16]). The D1 and D2 classes are thought to have different
evolutionary origin and are considered to have independently and
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mammals, dopaminergic modulation of direct pathway neurons is
dependent on dopamine D1 receptors, whereas modulation of
indirect pathway neurons is mediated by D2 receptors. In
lamprey, only a partial D1-like receptor gene has been cloned
[18] and shown to be expressed in a subpopulation of striatal
neurons [19]. Whether a D2 receptor is expressed in cyclostomes
and if so, whether this receptor is functional is the subject of the
present study. D2 receptors have previously only been identified
from the level of teleosts to primates (e.g. [17,20–23]). The
presence of a functional D2 receptor would provide important
additional evidence of the evolutionary conservation of the
receptor subtype and the operation of the basal ganglia circuitry.
Here, we identify a lamprey D2 receptor gene and show its
expression in a subpopulation of neurons in the striatum, where
tyrosine hydroxylase-positive (TH) boutons make synaptic contact
with striatal dendrites. In addition, we show that a D2 receptor
agonist reduces action potential discharge of striatal neurons, in a
similar manner to that observed in other vertebrates.
Results
Cloning and sequence analysis of lamprey dopamine D2
receptor
In order to identify a lamprey dopamine D2 receptor, the
human dopamine D2 receptor long chain (accession number
NM_000795) was aligned using BLAST against the sea lamprey
(Petromyzon marinus) genome (http://blast.ncbi.nlm.nih.gov). A
lamprey D2 receptor-like sequence sharing an 80% identity with
the human sequence was assembled and used as template. Table 1
shows the different primers used to obtain the 59 and 39 sequences.
In addition, we used the 59- and 39-RACE PCR to amplify the
respective sequences including the unconserved amino terminus
and to verify the start and stop codons. At least two sets of primers
were used to amplify the different regions.
The cloned D2 receptor cDNA sequence of the lamprey
comprises an open reading frame of 1533 nucleotides encoding a
protein of 511 amino acids. (Figure S1). The putative start codon
was identified by being embedded within a strong consensus motif
for a ribosomal binding site; with a G following ATG (position +4)
and a purine, G, three nucleotides upstream (position 23) (see
Figure S1; [24]). In addition, the BLAST analysis showed that the
length of the lamprey D2 receptor amino terminus is similar to
that of other vertebrates.
The D2 receptor sequence contains two highly conserved
regions. One conserved region was found in the 59 region
comprising 601 nucleotides and a second at the 39 end comprising
254 nucleotides (Figure 1A). In between the two conserved
regions, a sequence of 586 nucleotides, comprising the third
intracellular loop, shows little identity with other vertebrate D2
receptor sequences (Figures 1A, B, see also Figure 2). An
additional unconserved region was found at the 59 end comprising
95 nucleotides.
Transmembrane domains. The deduced amino acid
sequence exhibited the typical profile of a seven transmembrane
(TM) G-protein coupled receptor (GPCR). The first five TM
domains were located at the conserved 59 end, and TM 6 and 7
were located at the conserved 39 end (Figures 1B and 2). As
apparent in Figure 2, the lamprey dopamine D2 receptor shares a
very high identity within all TM domains, with the second and
third domains showing an 100% identity, when compared with the
TM domains of Homo sapiens, Mus musculus, Danio rerio and Anguilla
anguilla. Interestingly, when an amino acid differs in the lamprey it
mostly also differs in one or several of the other species examined.
The entire amino acid sequence in the lamprey shows around 60%
identity with other vertebrate D2 receptor protein sequences.
The lamprey protein contains highly conserved amino acid
residues that are thought to line the dopamine binding pocket
within the hydrophobic TM domains, in particular valine residues
in TM2, an aspartic acid residue in TM3, two serine residues in
TM5, and a highly conserved WLPFF sequence and a histidine
residue in TM6 [25,26]. Many characteristic features of GPCRs
were identified in the protein sequence of the lamprey D2
receptor, such as a conserved DRY sequence at the end of TM3,
which is mandatory for the interaction of the receptor with G
proteins [27]. The lamprey protein also contains several consensus
phosphorylation sites for protein kinases (PKC, PKA and CKII)
and a consensus N-glycosylation site in the NH2-terminus (see
Table 1. Primers (59 to 39) used for the cloning of the lamprey dopamine D2 receptor gene.
Forward primer Reverse primer
Fw-115/Re170 ATGCTTGCGGAGCTGCAGAGA TCGCCGTCTCGCGTGAAAAG
Fw-80/Re170 GCACATTTTGCCCAACCGCGA TCGCCGTCTCGCGTGAAAAGT
Fw128/Re767 TGCTCATATGCCTCATCGTC TCAAGCTTTGCACAATCGTC
Fw161/Re420 TCGTCTGCATCGCCGTCT GCTCTACAACACCCGCTACCG
Fw407/Re643 TCGCGATGCCCGTGCTCTACAAC ATCTACGTGGTCCCTGCGCAAGCG
Fw431/Re668 CCCGCTACCGGTCTCGACGGAGAGT GCAAAAGGGTCAACGCCAAGCGC
59 RACE Re410 CGATGCCCGTGCTCTACAACACCC
Fw469/Re957 TCTGTGGTTTGGGTCCTGTC CCAACAACACTCGCTCGG
Fw431/Re1497 CCCGCTACCGGTCTCGACGGAGAGT GTTCCGCAAGGCCTTCATTAAAA
Fw951/Re1492 GGCGAGCCAACAACACTC ATAGAGTTCCGCAAGGCCTT
Fw1289/Re1497 CGCAACAGAGAGAGAAGAAGGCGACTC GTTCCGCAAGGCCTTCATTAAAA
Fw1277/Re1492 ATCGGAATTTTTCGCAACAG ATAGAGTTCCGCAAGGCCTT
39 RACE Fw1290 GCAACAGAGAGAGAAGAAGGCGACTCA
39 RACE Fw1294 CAGAGAGAGAAGAAGGCGACTCAGATGC
Fw, forward; Re, reverse.
doi:10.1371/journal.pone.0035642.t001
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D2 class of dopamine receptors such as a relatively long third
intracellular loop and the carboxyl-terminal ending with a cysteine
residue (Figure 2; [27–29]).
Phylogenetic analysis. We focused our phylogenetic
analysis on the D2 receptor family as the BLAST analysis of the
lamprey cloned sequence showed identity with the D2 receptor
family, but not with the D1 receptor family. The deduced amino
acid sequence of the lamprey D2 receptor was aligned with
homologous D2 receptor sequences from other known vertebrate
representatives. The lamprey sequence was clustered together with
other vertebrate D2 sequences, not with the D3 or D4 receptor
subtypes, which shows that the lamprey sequence can be assigned
to the D2 receptor subtype, based on the primary amino acid
Figure 1. The lamprey dopamine D2 receptor. A. A schematic drawing of the lamprey dopamine D2 receptor nucleotide sequence showing the
conserved regions (black) at the 59 and 39 ends, respectively, and the site from which the riboprobe (660 bp, red) was made. B. The seven
transmembrane domains (TM-helix) are all located at the conserved parts of the dopamine D2 receptor. The deduced amino acid sequence of the
receptor shows that it belongs to the GPCR-superfamily.
doi:10.1371/journal.pone.0035642.g001
Figure 2. Alignment of dopamine D2 receptor amino acid sequences. Alignment of the deduced amino acid sequence from the lamprey
dopamine D2 receptor with those from Homo sapiens, Mus musculus, Danio rerio and Anguilla anguilla. The seven transmembrane domains are
indicated.
doi:10.1371/journal.pone.0035642.g002
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lamprey sequence is the most distant from the mammalian clade
(Figure 3). The cloned lamprey D2 receptor nucleotide sequence is
available in the GenBank (accession number HQ331119).
Dopamine D2 receptor mRNA expression
The riboprobe used contained the 59 conserved region, which
includes the first five transmembrane domains (see Figure 1A and
2). When the deduced protein sequence of the riboprobe was
aligned against other vertebrates using BLAST it showed a 92%
identity with the Anguilla anguilla, 90% with Danio rerio, 86% with
Mus musculus, and 86% with Homo sapiens D2 receptor protein
sequences. The specificity of the signals obtained by in situ
hybridization was confirmed using sense probes (see Figure 4D).
Background levels from all brain regions were very low in all
sections hybridized with
35S-UTP-labeled riboprobes.
In the striatum (Figure 4B), a high level of D2 receptor
expression was observed in the whole rostrocaudal extent
visualized with either DIG- or
35S-UTP-labeled riboprobes
(Figure 4A and C). Only a subpopulation of neurons within the
compact striatal cell layer expressed the receptor mRNA
(Figure 4C).
The preoptic area also expressed a high level of the D2 receptor
(Figure 4A). A small region just ventral to striatum and dorsal to
the preoptic area, the magnocellular preoptic nucleus, appears,
however, devoid of D2 receptor expression (Figure 4A). Further-
more, neurons in the dorsal and lateral pallium expressed the
receptor but at a lower level (Figure 4A). More caudally, high
levels of expression are observed in the habenula, thalamus and
hypothalamus as well as in the mammillary region (Figure 4E–H).
Retrograde tracing from the lamprey homologue of the SNr
leads to the labeling of only striatal projection neurons expressing
substance P and thus belonging to the direct pathway [6].
Consistent with these previous observations we showed retrograde
labeling of neurons in the striatum following the injection of
neurobiotin in the SNr (Figure 5A). In sections that were double-
labeled to reveal the retrogradely labeled neurons and the in situ
hybridization signal for the D2 receptor, the labels never
colocalized (Figure 5A–C; 38 retrogradely labeled neurons
analyzed). This finding supports the notion that D2 receptor
Figure 3. Phylogenetic analysis of vertebrate dopamine receptors of the D2-family. The distant tree was built with the neighbor-joining
algorithm from alignments of the D2, D3 and D4 receptor subtypes from several vertebrate species. Data were re-sampled by 1000 bootstrap
replicates to determine confidence indices within the phylogenetic tree. The scale bar refers to a phylogenetic distance of 0.09 amino acid
substitution per site. The different vertebrate classes are indicated by different colors (mammals, blue; birds, dark green; reptiles, light green;
amphibians, brown; fish, red; cyclostomes, mauve). GenBank accession numbers of the sequences are: Homo sapiens D2, AAA52761; Macaca mulatta
D2, XP_001085571; Bos taurus D2, DAA22356; Canis lupus familiaris D2, AAG34494; Mus musculus D2, NP_034207; Rattus norvegicus D2, NP_036679;
Gallus gallus D2, NP_001106761; Meleagris gallopavo D2, AAD03818; Anoils carolinensis D2, XP_ 003217484; Xenopus tropicalis D2, XP_002937871;
Xenopus laevis D2, CAA51412; Rana catesbeiana D2, BAI70438; Mugil cephalus D2, AAU87970; Oreochromis niloticus D2, AAU87971; Tetraodon
nigroviridis D2, CAF97490 ; Oncorhynchus mykiss D2, CAC87873; Danio rerio D2a, AAN87174; Danio rerio D2b, AAP94011; Anguilla anguilla D2A,
ABH06893; Anguilla anguilla D2B, ABH06894; Lampetra fluviatilis D2, ADO23655; Mus musculus D3, 2105315A; Rattus norvegicus D3, 1614344A; Canis
lupus familiaris D3, XP_545106; Homo sapiens D3, 1705199A ; Bos taurus D3, NP_001179824; Carassius auratus D3, ABN70936; Danio rerio D3,
AAN87173; Homo sapiens D4, 1709359A; Macaca mulatta D4, XP_001087197; Mus musculus D4, 2109259A; Rattus norvegicus D4, AAA18588; Danio
rerio D4a, AAW80614; Danio rerio D4b, AAW80615; Danio rerio D4c, AAW80616.
doi:10.1371/journal.pone.0035642.g003
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the lamprey and are thus likely to be those striatal neurons that
project to the GPe.
Ultrastructural localization of tyrosine hydroxylase-
immunoreactive structures
Previous studies have investigated the distribution of dopamine
neurons and fibers in the lamprey brain by using immunohisto-
chemical techniques at the light microscope level [9,30]. In this
study we characterized the presence of TH-immunoreactive fibers
in the striatum and perfomed a quantitative analysis of
dopaminergic profiles at the electron microscopic level to
determine synaptic incidence and the nature of the postsynaptic
structures in three regions of the lamprey striatum.
The striatum is densely innervated by long, TH-positive axons,
which are mainly distributed in areas III and I, with area II
containing slightly fewer immunoreactive profiles (Figure 6B). In
all areas, TH-positive profiles contained densely packed round
vesicles (Figure 6C–E) distributed throughout the axon, and were
commonly associated with two or more mitochondria. All
immunolabeled structures that formed synaptic contacts, formed
Figure 4. Dopamine D2 receptor expression in the lamprey brain. A.
35S-UTP-labeled D2 receptor riboprobe shows strong expression in the
striatum. D2 receptor expression is also present in the dorsal and lateral pallium although less strong. Note the absence of receptor expression in the
magnocellular preoptic nucleus (arrow). B. Nissl stained section from the striatum showing the site of receptor expression in A and C. C. DIG-labeled
D2 receptor riboprobe expressed in a subpopulation of striatal neurons. D. DIG-labeled sense riboprobe showing lack of mRNA expression in the
section adjacent to the one in Figure 5C. E.
35S-UTP-labeled D2 receptor riboprobe expression in the habenula, thalamus and hypothalamus. F.
Schematic drawing of the lamprey brain indicating the habenula, thalamus and hypothalamus. G.
35S-UTP-labeled D2 receptor riboprobe shows
strong expression in the mammillary area. H. Schematic drawing of the lamprey brain indicating the mammillary area. The pseudocoloring in A, E
and G indicates signal intensity from low (black/blue) to high (pink/yellow). Abbreviation: DPal, dorsal pallium; Hb, habenula; Hyp, hypothalamus; LPal,
lateral pallium; MAM, mammillary region; ot, optic tract; OT, optic tectum; PO, preoptic nucleus; Str, Striatum; Th, thalamus. Scale bars, A, B, E and G
500 mm; C and D 200 mm.
doi:10.1371/journal.pone.0035642.g004
Figure 5. Striatal projection neurons targeting substantia nigra pars reticulata (SNr) do not express the D2 receptor. A. Striatal neurons
retrogradely labeled after injections of neurobiotin into the SNr (white arrows). B. DIG-labeled D2 receptor riboprobe expressed in a subpopulation of
striatal cells (black arrow heads show examples of positive cells). C. Merged image showing the absence of overlap between retrogradely labeled
cells and D2 receptor mRNA expression. Scale bars, 100 mm.
doi:10.1371/journal.pone.0035642.g005
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long synaptic specialization, presynaptic vesicle accumulation, a
thick postsynaptic density, a widened synaptic cleft and cleft
material (Figure 6C–E).
In all three areas (I, II and III) the postsynaptic structures were
dendrites that varied in size and shape, some of them having a
stubby (Figure 6D) or spine-like appearance. We did not observe
any immunopositive boutons establishing synapses of the symmet-
rical type (Gray’s type 2) or making contact with a cell body.
The synaptic incidence analysis on the serial sections of the TH-
labeled axonal profiles demonstrates that most do not form a
synaptic junction within six consecutive sections. The proportion
of TH-labeled axons that make synapses in area III was 31%,
which was significantly higher than the synaptic incidence
observed in area I (x
2 test, p=0.0003) and area II (x
2 test,
p=0.0022), where only 7 and 9% of labeled profiles formed
synapses, respectively (Figure 6F).
Figure 6. Tyrosine hydroxylase (TH) immunoreactivity in the lamprey striatum. A and B. Light microscope photomicrographs showing
the areas (I, II and III) of the striatum that were included in the electron microscope analysis. Note the slightly higher density of TH-immunoreactive
fibers (some indicated by small arrows) in Areas I and III. C–E. Electron micrographs of TH-immunolabeled axonal profiles forming asymmetrical
synapses (arrows) with dendritic shafts (d) in Area I (C), II (D) and III (E) of the lamprey striatum. Note the densely packed vesicles and the prominent
postsynaptic densities. F. Quantitative analysis of synaptic incidence in the three areas of striatum. The histogram shows the average percentage of
TH-immunolabeled profiles which form synaptic junctions (out of a total of 75 profiles per area, n=3). Synaptic incidence in Area III was significantly
higher when compared to Area I (x
2 test, p=0.0003) and Area II (x
2 test, p=0.0022). Abbreviations: vt, ventriculus medius telencephali; lpv, ventral part
of the lateral pallium. Scale bars: A: 200 mm, B: 100 mm, C–E: 200 nm.
doi:10.1371/journal.pone.0035642.g006
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In mammals and birds, selective activation of D2 receptors
reduces the overall excitability of striatal projection and interneu-
rons through modulation of intrinsic and synaptic properties
[12,31,32]. To investigate the effects of D2 receptor activation on
lamprey striatal neurons, we applied the selective D2 agonist,
TNPA, during whole cell current-clamp recordings.
Depolarizing current steps from a slightly depolarized baseline
of -65 mV applied to striatal neuron elicited a series of action
potentials (Figure 7A1–A3). Application of 100 mM TNPA
markedly reduced the number of evoked spikes (Figure 7A2).
Comparison of the spike frequency of evoked action potential at
twice the threshold current for evoking a spike revealed a marked
and significant reduction in 5 of 6 neurons in the presence of
TNPA (control 6.462.5 Hz; TNPA 3.663.6; p,0.05; n=6;
Figure 7B). The reduction was not affected by changing the
baseline from which action potentials were evoked.
At the termination of hyperpolarizing current steps a post-
inhibitory rebound (PIR) depolarization occurred with superim-
posed spikes (Figure 7A1, control). This occurs at the baseline level
of 265 mV, but not at holding-potentials below 280 mV (n=6).
During TNPA application, the number of PIR spikes (Figure 7A2
and C) was markedly reduced (control 1.960.9; TNPA 0.360.5;
p,0.05; n=6). Moreover, when rebound spikes were seen in the
presence of TNPA, they tended to occur much later after the end
of the hyperpolarizing pulse (Figure 7D). TNPA also affected the
size and shape of evoked action potentials and PIR spikes
(Figure 7E).
Discussion
This study represents the first description of the lamprey
dopamine D2 receptor cDNA and its expression pattern in the
forebrain. We revealed a strong and distinct expression of the D2
receptor mRNA in the striatum. The same region contains TH-
immunoreactive synaptic terminals. Moreover, D2 receptor
agonists were found to exert similar cellular effects on striatal
neurons as established in mammals [12].
The lamprey dopamine D2 receptor gene
Our analysis of the nucleotide and deduced amino acid
sequence of the lamprey D2 receptor demonstrates that it is a
member of the superfamily of G-protein coupled receptors and
belongs to the D2 receptor subtype. The gene has two highly
conserved parts that comprise all the TM domains containing the
amino acids necessary for binding of dopamine [25,26]. The
unconserved intermediate part that forms the third intracellular
loop differs, however, largely from other vertebrates. The longer
coding sequence of the lamprey D2 receptor compared to the
human long isoform, 1533 bp versus 1332 bp, is mainly due to its
longer third cytoplasmic loop. A phylogenetic analysis of the
cloned D2 receptor gene rooted the lamprey protein sequence at
the base of the D2 receptor tree and furthest from the human D2
receptor in line with lamprey having emerged earlier than any of
the other vertebrate species (approximately 560 million years ago;
[8]). In mammals, birds and most teleosts, only one D2 receptor
gene has been found that encodes for the two protein isoforms, the
D2 long and D2 short isoforms [33,34]. Likewise, we only
identified one gene encoding for a dopamine D2 receptor, as is the
case for the D1-like receptor in lamprey and hagfish [16].
However, in three teleosts (zebrafish, trout and eel), multiple D2
receptors have been identified [23,35,36]. Compared to other
gnathostomes, an additional duplication event (3R) is thought to
have occurred in the teleost lineage [37]. It is likely that in most
cases this additional duplicate has been lost, whereas a
subfunctionalization of ancestral functions has been proposed to
explain the conservation of both D2 receptor duplicates. In
Figure 7. Modulation of striatal neurons by a dopamine D2 agonist. A. Voltage responses of a striatal neuron to 1 s long hyperpolarizing
and depolarizing current injections during control (A1), D2 agonist application (TNPA, A2) and washout (A3). B. The number of evoked action
potentials is reduced upon application of TNPA, measured here at twice the threshold stimulation. C. The average number of PIR spikes is reduced by
TNPA, measured after termination of five consecutive hyperpolarizations in between 2100 and 280 mV. D. The total number of PIR spikes and the
time until the spike are reduced by TNPA, measured as in C. E. Table of firing properties before and during TNPA. All values presented as mean 6 SD
and differences were significant for all measurements apart from the AP half-width (p,0.05, student’s t-test). Abbreviations: AP, action potential; PIR,
post-inhibitory rebound; TNPA, trihydroxy-N-propyl-noraporphine 123 hydrobromide hydrate.
doi:10.1371/journal.pone.0035642.g007
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occurred, but according to our results the receptor analyzed
clearly corresponds to the mammalian D2 subtype. The D2
receptor is likely to be rather conserved in the vertebrate lineage
even in teleosts, where the ancestral functions were maintained
despite the existence of additional D2 receptors, although
additional analyses are still necessary to confirm this assumption.
Expression of D2 receptors in the forebrain
In mammals, a clear difference between the D1 and D2
receptor expressing striatal neurons is evident at the molecular,
anatomical, and physiological levels (for review see [12]). The high
levels of D2 mRNA receptor expression in a subpopulation of
striatal cells, as well as the absence of D2 expression in striatal cells
of the direct pathway, indicate that also in lamprey, there is a
segregation between these two cell-types. This is further supported
by our recent studies that pallidal GPi neurons are mainly apposed
by substance P-positive fibers/terminals, whereas GPe neurons are
apposed by enkephalin-positive structures and that SNr projecting
striatal cells are substance P-immunoreactive [6,7].
High levels of D2 receptor expression were also observed in the
preoptic area, habenula, mammillary region, hypothalamus, and
thalamus. In all other vertebrates investigated, these regions are
rich in D2 receptor expression (e.g. [22,23,35,38,39]) which gives
further evidence that our cloned D2 receptor is indeed, a member
the D2 receptor subfamily. A small region of the preoptic area, the
magnocellular preoptic nucleus, lacked D2 expression, as is the
case in the trout [35].
Although the dopamine D2 and D3 receptors belong to the
same class of dopamine receptors their expression pattern in the
vertebrate brain is very different. Overall, the D2 receptor is by far
the more highly expressed subtype and is found in all major brain
areas receiving dopaminergic projections, particularly the dorsal
striatum. The D3 receptor is not only expressed at a lower levels
but it also shows a fairly restricted pattern of expression (e.g.
islands of Calleja, nucleus accumbens and cerebellum) [29,40,41].
The robust general expression pattern of the D2 receptor in
lamprey brain further supports our conclusion that it belongs to
the D2-subfamily.
Dopaminergic terminals in striatum
The striatum in lampreys receives a dense dopaminergic
innervation that originates in the nucleus tuberculi posterioris in
the diencephalon [9]. The general distribution pattern of
dopamine-immunoreactive neurons in this nucleus is similar to
that obtained using antibodies against aromatic L-amino acid
decarboxylase or TH [9,30,42] and furthermore this nucleus does
not express the enzymes involved in the synthesis of noradrenaline
or adrenaline [42] implying that the neurons are dopaminergic.
The present immunocytochemical findings confirm and extend
previous findings relating to TH innervation of the lamprey
striatum and demonstrate that TH-immunoreactive axonal
profiles are densely packed with synaptic vesicles and form typical
asymmetric synaptic specializations. Thus, similar to mammals,
the lamprey striatum receives a dense innervation from TH-
positive fibers. However, there are differences in the ultrastructural
features in terms of their size, type of specialization and
distribution of postsynaptic targets. In rodents, TH-positive
boutons form symmetrical synapses (Gray’s type 2) with both
spines and dendritic shafts and occasionally with cell bodies [43–
45]. Their synapses are very small and membrane specializations
are often difficult to discern. In contrast, in the lamprey striatum
dopaminergic terminals form exclusively asymmetric synapses
with dendrites which, in addition, have large and prominent
synaptic specializations. Furthermore, our quantitative analysis
shows that around 30% of labeled TH-positive profiles observed in
Area III form synaptic contacts (when examined in 6 serial
sections), whereas profiles located in Areas I and II show a
significantly lower synaptic incidence (Figure 6F). Although this
degree of synaptic incidence in Areas I and II is similar to that
observed in mammals, the synaptic incidence in Area III is higher
and may suggest that dopaminergic transmission has different
characteristics in this region. It is interesting to note that a single-
cell analysis of intracellularly labeled Area II striatal neurons [10]
revealed that their dendrites branch more profusely in Area III, i.e.
the region in which dopaminergic axons are most likely to form
synapses. Overall, our study reveals new aspects of the distibution
and fine structural features of the dopaminergic system of the
lamprey brain. Furthermore, our data provide the structural basis
to support the modulatory role of dopamine within this area and
thereby its contribution to basal ganglia functions in the lamprey
brain.
Modulation of dopamine in the striatum
D2 receptor activation modulates neuronal excitability through
inhibition of voltage sensitive Ca
2+ channels, inactivation of Na
+
channels and activation of K
+ channels [29,46,47]. In the present
study we observed a marked reduction of discharge in lamprey
striatal neurons upon D2 receptor activation, a finding that is
consistent with results from reptiles, birds and mammals
[31,32,48]. The D2 receptor agonist, TNPA, shifted the threshold
to more depolarized levels for both action potentials and PIR
spikes, as well as reducing their amplitudes. This is similar to
observations in mammals where D2 activation appears to enhance
slow inactivation of Na
+ channels, an effect that also contributes to
the reduction in the PIR response in cholinergic interneurons [49].
In mammalian striatal projection neurons, a reduced excitability
has also been associated with a negative modulation of the L-type
Cav 1.3 Ca
2+ channel [48,50]. In the lamprey spinal cord, a
depression of Cav 1.3 Ca
2+ channels by D2 receptor activation has
also been described [51]. This is consistent with our findings,
where application of TNPA profoundly reduces the number of
PIR spikes. The fact that PIR spikes were almost only elicited
upon hyperpolarization from a depolarized baseline around
265 mV or more, further suggests Cav 1.3 channels to be
involved since this is within their activation range [52].
In mammals, D2 receptors are expressed in neurons that project
to the GPe, as part of the indirect pathway [53]. Selective
acivation of the indirect pathway medium spiny neurons leads to
an inhibition of movements [54], presumably by increasing the
inhibitory output of the GPi/SNr [12]. The indirect pathway has
been oberserved in lamprey and may represent a common
vertebrate mechanism for inhibiting actions [7,54]. Application of
dopamine or D2 receptor antagonists cause a decrease in the
excitability of mammalian indirect pathway medium spiny
neurons [48,55], whereas dopamine increases the excitability of
medium spiny neurons that express the D1 receptor and project
directly to the GPi/SNr [56,57]. The dicotomous effects of
dopamine on these pathways is therefore believed to bias the
network to promote actions, by decreasing the excitability of the
indirect pathway that suppresses actions and by increasing the
excitability of the direct pathway that promotes actions. Our
results show that lamprey striatal neurons express the D2 receptor
and that D2 receptor agonists decrease the excitability of striatal
neurons. This suggests that the direct and indirect pathways are
not only conserved throughout vertebrate phylogeny as a common
mechanism for action selection but that dopmine will play a
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to bias the network for action selection.
Conclusion
The present identification of a functional dopamine D2 receptor
and the structural basis for the modulatory role of dopamine in the
lamprey striatum gives additional evidence for the presence of an
indirect pathway and that the ancestral basal ganglia circuitry is
evolutionary conserved. The resemblances in gene structure
between different vertebrate D2 receptors furthermore show that
the fundamental function of these receptors is a conserved feature.
Material and Methods
Ethical statement
Experiments were performed on a total of 32 adult river
lampreys (Lampetra fluviatilis) of either sex. The experimental
procedures were approved by the local ethical committee (Stock-
holm’s Norra Djurfo ¨rso ¨ksetiska Na ¨mnd) and were in accordance
with The Guide for the Care and Use of Laboratory Animals (National
Institutes of Health, 1996 revision). During the investigation, every
effort was made to minimize animal suffering and to reduce the
number of animals used.
Molecular cloning and sequencing of the lamprey
dopamine D2 receptor
RNA isolation. Animals (n=9) were deeply anesthetized in
tricane methane sulfonate (MS-222; 100 mg/L; Sigma-Aldrich,
St. Louis, MO, USA) diluted in fresh water and the brains were
quickly removed and frozen on dry ice. Total RNA was extracted
using Trizol reagent (Invitrogen, La Jolla, CA, USA) or RNeasy
Mini Kit (Qiagen, Valencia, CA, USA) and quantified by
spectrophotometry using NanoDropH ND-1000
spectrophotometer (NanoDrop Technologies, Wilmington, DE,
USA). The integrety and purity of the RNA preparations were
analysed by means of gel electrophoresis on Experion bioanalyzer
(Bio-Rad Laboratories, Hercules, CA, USA). Only RNA with RQI
values between 9.9 and 10 (max value 10) was used for cDNA
synthesis.
cDNA synthesis. The first-strand cDNA synthesis from total
RNA was performed with RETROscript reverse transcriptase
(Ambion Inc, Huntingdon, UK) and Oligo (dT) or Random
decamers. Identical results were obtained with both.
PCR amplification. For polymerase chain reaction (PCR)
amplification, degenerate oligonucleotide primers were designed
based on alignment of the human dopamine D2 receptor
(GenBank accession number NM_000795) with the lamprey
(Petromyzon marinus WGS) genome sequences deposited in the
trace archives at the NCBI (National Center for Biotechnology
Information, Bethesda, MD, USA). Primers (see Table 1) were
designed to amplify different parts of the predicted lamprey D2
receptor sequence using Primer3 software (Whitehead Institute/
Massachusetts Institute of Technology, Boston, MA) and
purchased from Invitrogen. In addition, we used the SMART
RACE cDNA amplification kit (Clontech Laboratories, Palo Alto,
CA; see below) to obtain the unconserved amino terminus and to
verify the start and stop codons. All primers had a GC content
between 50 and 61%. The amplified cDNA fragments were
cleaned directly with the MinElute PCR Purification kit (Qiagen)
or cloned into a pCRHII-TOPOH vector (Invitrogen, see below)
and then confirmed by nucleotide sequencing (KIGene, Core
Facility at Karolinska Institutet, Stockholm, Sweden).
59- RACE. First strand cDNA was synthesized from total
RNA using a modified lock-docking oligo (dT) primer (59-RACE
cDNA synthesis primer) and SMARTer IIA oligo, following the
manufacturer’s instructions (Clontech). The first strand cDNA was
used as a template for PCR amplification with a gene specific
primer (Table 1) and a universal primer mix containing the
complementary sequence to the SMART oligo. The 59-RACE
PCR was performed in 50 mL reactions using Clontech Advantage
2 Polymerase Mix following the manufacturer’s instruction
(Clontech). The amplified fragment was cloned using the TOPO
TA CloningH Kit with pCRHII-TOPOH vector and One ShotH
TOP10 Chemically Competent cells following the manufacturer’s
instructions (Invitrogen). Transformed bacteria were grown
overnight at 37uC on LB agar plates. Twelve bacteria colonies
were selected and grown overnight in Terrific Broth (Sigma) at
37uC. Plasmid DNA purification was subsequently performed
using the Bio-Rad Quantum Prep Plasmid Miniprep Kit (Bio-Rad
Laboratories, Sundbyberg, Sweden). Purified DNA fragments
were confirmed by nucleotide sequencing (KIGene).
39-RACE. First strand cDNA was synthesized from total RNA
using a modified lock-docking oligo (dT) primer (39-RACE cDNA
synthesis primer) according to the manufacturer’s instructions
(Clontech). For the gene specific primers used see Table 1.
Sequence analysis
Sequence analysis and comparisons were made with the Basic
Local Alignment Search Tool (BLAST) on NCBI and/or the CLC
Sequence Viewer 6.4. The start site of translation for the putative
lamprey dopamine D2 receptor was determined based upon the
following: i) the putative start codon being embedded in a
consensus motif of a ribosomal binding site (see [24], ii) the open
reading frame using ORF finder at NCBI (http://www.ncbi.nlm.
nih.gov) and iii) by BLAST analysis (comparing the putative
lamprey protein sequence with D2 receptor proteins of other
known vertebrate species).
Transmembrane domains predictions were made with Octopus
(http://octopus.cbr.su.se/). Putative N-glycosylation and phos-
phorylation sites were analyzed using PredictProtein-Sequence
Analysis, Structure and Function Prediction (http://www.
predictprotein.org).
The amino acid sequence of the lamprey dopamine D2-like
receptor was aligned with homologous D2 receptor sequences
from other known vertebrate representatives using BLAST and
Geneious (http://www.geneious.com). Dopamine D3 and D4
receptor sequences were also included in the analysis. A
phylogenetic tree was constructed with the neighbor-joining
method from this alignment. Detailed analysis and alignments
were also made with Homo sapiens (NP_000786.1), Mus musculus
(NP_034207.2), Danio rerio (NP_898891.1) and Anguilla anguilla
(ABH06893.1) D2 receptor proteins using CLC Sequence Viewer
6.
Probes for in situ hybridization
Templates for in vitro transcription were prepared by PCR
amplification. A 660 base pair (bp) fragment (see Figure 2A) was
obtained using 59-TGCTCATATGCCTCATCGTC-39 forward
and 59-TCAAGCTTTGCACAATCGTC-39 reverse primers.
The amplified cDNA fragment was cloned into a pCRHII-
TOPOH vector (Invitrogen), cleaned and confirmed by nucleotide
sequencing (KIGene). Linearized plasmids (1 mg) were used to
synthesize [
35S] UTP- and digoxygenin (DIG)-labeled riboprobes.
In vitro transcription was carried out using the MAXIscript
TM
SP6/T7 kit (Applied Biosystems, Uppsala, Sweden) and [a35-
S]UTP (NEG039H; Perkin Elmer, Upplands Va ¨sby, Sweden) or
DIG RNA Labeling Mix (Roche Diagnostics, Nutley, NJ, USA)
according to the manufacturer’s instructions. The transcripts were
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TM spin columns (Applied Biosystems).
Sense probes were used as negative controls.
In situ hybridization
Adult river lampreys (n=12) were deeply anesthetized in MS-
222 (100 mg/L) diluted in fresh water. Brains were quickly
removed and fixed in 4% paraformaldehyde or 4% formaldehyde
in 0.01 M phosphate buffered saline (PBS) overnight at 4uC. The
tissue was cryoprotected in 20% sucrose in 0.01 M PBS overnight
and 20 mm thick serial, transverse cryostat sections were cut
through the brain and stored at 280uC until further processing. In
each in situ hybridization that we performed one series of sections
was used for the anti-sense probe and the adjacent series was used
for the sense probe.
In situ hybridization with
35S-UTP-labeled
riboprobes. The sections were left at room temperature for
30 min, washed in 0.01 M PBS, treated with 0.05 M HCl for
10 min, washed in DEPC-treated water and then 0.01 M PBS,
acetylated in 0.25% acetic anhydride in 0.1 M triethanolamine
(pH 8.0) for 15 min, washed in 0.01 M PBS and dehydrated in
70%, 80% and 100% ethanol (2 min each). Sections were air dried
and prehybridized (50% deionized formamide (pH 5), 50 mM
Tris-HCl (pH 7.6), 25 mM EDTA (pH 8.0), 20 mM NaCl,
0.25 mg/ml yeast tRNA, 2.56 Denhardt’s solution) for 4 h at
55uC. Sections were then hybridized overnight (14–16 h) at 55uC
with labeled probes diluted to a final concentration of 1.06
10
6 cpm/200 mL in a solution containing 50% deionized
formamide, 0.3 M NaCl, 20 mM Tris-HCl (pH 7.6), 5 mM
EDTA (pH 8.0), 10 mM PBS, 0.2 mM dithiothreitol, 0.5 mg/ml
yeast tRNA, 0.1 mg/ml poly-A-RNA, 10% dextran sulfate, and
16Denhardt’s solution. After hybridization, the slides were rinsed
in 16standard saline citrate (SSC), 0.01% sodium dodecyl sulfate
(SDS: 15 min); 16SSC, 0.01% SDS (30 min); 50% formamide/
0.56SSC (1 h); 16SSC, and 0.01% SDS (15 min) at 55uC with
continuous shaking. The sections were then treated with 1 mg/mL
RNase A (Roche, Diagnostics) in RNase buffer (0.5 M NaCl,
10 mM Tris-HCl, 5 mM EDTA, pH 8.0) for 1 h at 37uC. After
two additional washes in 16 SSC, 0.01% SDS for 30 min, the
sections were dehydrated in ascending alcohol series and air-dried.
Sections were placed against b-Max film (VWR, Sweden) and
stored at room temperature for 3 to 5 days. Films were developed
in Kodak D19 developer for 2 min and in Kodak Unifix liquid
fixative for 5 min. Films were scanned with Epson Perfection 4990
Photo scanner as gray scale film. The gray scale was converted to
pseudocolors using ImageJ (NIH ImageJ version 1.45, U.S.
National Institutes of Health).
In situ hybridization with DIG-labeled
riboprobes. Sections were handled as above excluding the
HCl treatment. After prehybridization (50% formamide, 56SSC
pH 7.0, 56Denhardts’s, 500 mg/mL salmon sperm DNA,
250 mg/mL yeast RNA) for 2–4 h at 60uC, DIG-labeled sense
and anti-sense riboprobes were prepared and added to the
hybridization solution to a final concentration of 500 ng/mL and
hybridized overnight at 60uC. An RNAse treatment (20 mg/mL in
26SSC) was performed for 30 min at 37uC following stringent
washes in SSC (Applied Biosystems). After additional washes in
maleic acid buffer (pH 7.5) the sections were incubated overnight
at 4uC in alkaline phosphatase labeled sheep anti-DIG antibody
(1:2000; Roche Diagnostics) in 10% heat inactivated normal goat
serum (NGS; Vector Laboratories, Burlingame, CA). The alkaline
phosphatase was visualized using BCIP/NBT (Roche Diagnostics)
in TRIS buffer pH 9.5 without the addition of MgCl2. The
sections were dehydrated and mounted in DPX (Sigma).
Photomicrographs were taken in an Olympus BX51 microscope
using the image acqusition program Cell
A and adjusted for
brightness and contrast with Adobe Photoshop CS4.
Retrograde tracing
Animals (n=2) were deeply anesthetized in MS-222 in ice-
cooled oxygenated HEPES buffered physiological solution (in
mM: 138 NaCl, 2.1 KCl, 1.8 CaCl2, 1.2 MgCl2, 4 glucose, and 2
HEPES; pH 7.4). 50–200 nL 20% neurobiotin (Vector Labora-
tories) was pressure injected unilaterally into the lamprey
homologue of the SNr, located in the dorsolateral isthmic region.
All injections were made with glass micropipettes (borosilicate,
OD=1.5 mm, ID=1.17 mm). Following the injections, the
animal were returned to their aquarium for 24 h. Following
anesthesia, fixation, sectioning of the brain and in situ hybridiza-
tion of striatal sections with DIG-labeled D2 receptor riboprobes
(see above), the tissue was incubated with Cy3-streptavidin
(1:1000; Jackson Immunoresearch, West Grove, PA) to reveal
the neurobiotin, rinsed in PBS and mounted in glycerol containing
2.5% DABCO (Sigma-Aldrich). The total number of retrogradely
labeled cells in the striatum was counted in two animals.
Photomicrographs were taken in an Olympus BX51 microscope
with an Olympus XM10 CCD camera (black and white), using the
image acqiusition program Cell
A and adjusted for brightness and
contrast with Adobe Photoshop CS4.
Preparation and analysis of tissue for electron
microscopy
Tissue preparation. Following anesthesia, lamprey brains
(n=3) were immersion-fixed overnight in 4% formaldehyde, 14%
saturated picric acid solution and 0.1% glutaraldehyde in 0.1 M
phosphate buffer (PB; pH 7.4) at 4uC, and then transferred to
0.1 M PB until processing. The brains were embedded in 5% agar
and sectioned at 50 mm in the coronal plane using a vibrating
microtome (VT1000S; Leica Microsystems, Wetzlar, Germany).
Immunohistochemistry. The sections were incubated in a
cryoprotectant solution (0.05 M phosphate buffer, 25% sucrose,
10% glycerol) overnight, then freeze-thawed twice in liquid
nitrogen in order to increase penetration of the reagents. The
sections were washed thoroughly and then incubated in 10% NGS
(Vector Laboratories) in PBS for 2 h at room temperature. All
sections were immunolabeled to reveal TH-containing structures
using a rabbit anti-TH antibody (1:500 in NGS-PBS; Millipore
AB152). The sections were incubated overnight at room
temperature, washed in PBS and incubated at 4uC with a
biotinylated goat anti-rabbit secondary antibody (1:300 in NGS-
PBS; Vector Laboratories) for about 16 h. This was followed by
incubation in an avidin-biotin-peroxidase complex (ABC Elite;
Vector Laboratories) for 3–4 h at room temperature. The sections
were then washed in PBS followed by washes in Tris-buffer
(0.5 M, pH 7.6; TB). The sections were pre-incubated in
diaminobenzidine (DAB 0.025% in TB) with shaking for 15 min
and the peroxidase reaction was initiated by the addition of H2O2
to a final concentration of 0.01%. The reaction was allowed to
continue for 3–5 min and stopped by several washes in TB and
then PB. The sections were postfixed in 1% osmium tetroxide in
PB for 15–20 min and dehydrated as described previously [45].
Following absolute ethanol, sections were washed twice in
propylene oxide (Sigma) for 15 min and placed into resin
overnight at room temperature (Durcupan ACM, Fluka,
Gillingham, UK). They were then mounted in resin on glass
slides and the resin was polymerized at 60uC for 48 h.
Electron microscopic analysis. It has previously been
shown [9] that striatal neurons and neuropil are organized into
three layers, characterized as follows: Area I is defined by the
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faces the ventriculus medius telencephali; Area II contains most of the
striatal cell bodies arranged as a single band. These neurons
possess two major processes that extend and branch in opposite
directions, medially towards Area I and laterally towards Area III,
which also contains scattered cell bodies. Each of these regions
were investigated for the presence of TH-immunoreactive synaptic
terminals and the nature of the postsynaptic targets.
Regions of the sections that contained Areas I, II and III
(Figure 7 A, B) were cut out from the slide and re-embedded in
Durcupan blocks. Serial sections (50–60 nm) were cut using an
ultramicrotome (Leica EM UC6, Leica Microsystems) and
collected on pioloform-coated, single-slot copper grids (Agar
Scientific, Stansted, UK). To improve contrast, the ultrathin
sections were lead-stained for 4–5 min and then examined in a
Philips CM100 electron microscope.
TH-immunoreactive structures were identified by the electron
dense peroxidase reaction product that adhered to the internal
surface of the plasmalemma and the outer membrane of organelles
and axonal profiles were identified by the presence of synaptic
vesicles and often mitochondria. TH-immunolabeled profiles
located in the three different areas were noted and digitally
recorded at different magnifications using a Gatan CCD camera.
Each profile was examined in each of the six serial sections to
determine whether they form of a synaptic specialization and to
characterize the nature of the postsynaptic target. Any other
immunopositive axonal profile seen in a subsequent serial section
was also noted and analyzed in all sections. This process was
repeated on sections from different grids until 25 TH-immuno-
positive profiles were analyzed per area per animal. In total, 225
TH-positive profiles were included in the analysis. A total of
aproximately 40,000 square micrometer were examined per
animal.
The digital images were analyzed using Image J, and they were
adjusted for contrast and brightness using Adobe Photoshop CS3.
Synapse formation throughout the serial sections was scored for
each TH-positive axonal profile. For each such synapse, the
postsynaptic target was characterized. All synapses observed were
of the asymmetrical type (Gray’s type 1) and were characterized as
such by the presence of presynaptic vesicle accumulation, a thick
postsynaptic density, a widened synaptic cleft and cleft material.
Structures which did not fulfill these criteria were not considered
as synaptic junctions.
Statistical analyses were performed using the statistical software
R (version 2.13.1). Data were presented as means and standard
deviations and comparisons made using chi-squared test with
Yates continuity correction. Tests with p,0.05 were considered
significant.
Electrophysiology in lamprey striatal slices
Acute striatal brain slices were prepared from anesthetized (MS-
222, 1 mg/100 mL) lamprey as described in Ericsson et al. [58].
Brains were quickly dissected out from decapitated lampreys in
ice-cold artificial cerebrospinal fluid (aCSF) of the following
composition (in mM): NaCl 125, KCl 2.5, NaH2PO4 1.25, MgCl2
1, glucose 10, CaCl2 2 and NaHCO3 25. Sectioning of the brain
was performed with a tissue chopper (Vibratome 800 tissue
Chopper, Leica Microsystems AB, Sweden) to obtain coronal
slices of 350 mm thickness. The slices were transferred to a
recording chamber and continuously perfused with aCSF (pH 7.4)
that was oxygenated with 95% O2 and 5% CO2. The chamber
was kept at 5–8uC with a Peltier cooling block (Elfa, Stockholm,
Sweden). Slices were left to recover for at least one hour before
patch clamp experiments were commenced. Recordings were
performed in whole-cell current- or voltage-clamp mode with
patch pipettes of 5–12 MV filled with (in mM): 105 K-gluconate,
30 KCl, 10 HEPES, 4 Mg-ATP, 0.3 Na-GTP and 10
phosphocreatine sodium salt (osmolarity 275 mOsm). Pipettes
were prepared from borosilicate glass microcapillaries (Harvard
Apparatus, Kent, UK) using a three-stage puller (Model P-97,
Sutter Instruments, Novato, CA, USA). Neurons were visualized
with DIC/infrared optics (Olympus BX51WI, Tokyo, Japan) and
pipettes advanced with remote-controlled micromanipulators
(Luigs & Neumann, Ratingen, Germany). An Axoclamp 2B
amplifier (Molecular Devices Corp., CA, USA) was used together
with a HS-2A headstage (Molecular Devices Corp.) for recordings
and signals digitized (ITC-18, HEKA, Lambrecht, Germany) at
10–50 kHz before storage on a PC. Bridge balance and pipette
capacitance compensation were adjusted on the amplifier and
membrane potential values were corrected for the liquid junction
potential. Data was acquired and analyzed using Igor software
(version 6.03, WaveMetrics, Portland, USA).
The dopamine D2 receptor agonist TNPA (R(2)-2,10,11-
Trihydroxy-N-propyl-noraporphine 123 hydrobromide hydrate;
Sigma-Aldrich), was freshly prepared as 100 mM in 99.5%
ethanol before dilution to 100 mM in aCSF. TNPA was then
bath-applied through the perfusion system.
Statistical analyses were performed with GraphPad Prism
Software (GraphPad Software, San Diego, CA, USA) and
comparisons between means were made with two-tailed paired t-
tests. Results are presented as mean 6 standard deviation (SD).
Supporting Information
Figure S1 Nucleotide and deduced amino acid sequenc-
es of the lamprey dopamine D2 receptor. The coding
region is 1533 base pair long and its deduced amino acid sequence
spans 511 amino acids. The numbering of the deduced amino acid
sequence begins with the first methionine of the open reading
frame, and is shown to the right of each line. The nucleotide
numbers are shown to the left of each line. The untranslated
regions are shown in smaller fonts. Putative N-glycosylation sites,
blue squares; protein kinase C phosphorylation sites, green
squares; cAMP phosphorylation site, pink square; Casein kinase
II (CKII) phosphorylation site, orange squares.
(TIF)
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